Back
Syndax Pharmaceuticals 10K Form
Sell
46
SNDX
Syndax Pharmaceuticals
Last Price:
21.54
Seasonality Move:
17.13%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-11-05 | 10Q | SNDX/Syndax Pharmaceuticals Quarterly |
2020-08-06 | 10Q | SNDX/Syndax Pharmaceuticals Quarterly |
2020-05-07 | 10Q | SNDX/Syndax Pharmaceuticals Quarterly |
2020-03-05 | 10K | SNDX/Syndax Pharmaceuticals Annual |
2019-11-07 | 10Q | SNDX/Syndax Pharmaceuticals Quarterly |
2019-08-07 | 10Q | SNDX/Syndax Pharmaceuticals Quarterly |
Receive SNDX News And Ratings
See the #1 stock for the next 7 days that we like better than SNDX
SNDX Financial Statistics
Sales & Book Value
Annual Sales: | $139.71M |
---|---|
Cash Flow: | $-22.89M |
Price / Cash Flow: | 0 |
Annual Sales: | $6.86 |
Price / Book: | 3.13 |
Profitability
EPS (TTM): | -2.45000 |
---|---|
Net Income (TTM): | $-149.34M |
Gross Margin: | $0 |
Return on Equity: | 0% |
Return on Assets: | 0% |
Syndax Pharmaceuticals Earnings Forecast
Key Syndax Pharmaceuticals Financial Ratios
- The Selling, General & Administrative Expenses for SNDX have been equal to 18.07% of Gross Profit Margin.
- The Interest Expense is -2.10% of Operating Income.
- Per Share Earnings over the last 11 years have been positive in 5 years.
Syndax Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Healthcare |
Current Symbol: | SNDX |
CUSIP: | 87164F |
Website: | syndax.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
SNDX Technical Analysis vs Fundamental Analysis
Sell
46
Syndax Pharmaceuticals (SNDX)
is a Sell
Is Syndax Pharmaceuticals a Buy or a Sell?
-
Syndax Pharmaceuticals stock is rated a Sell
The current Syndax Pharmaceuticals [SNDX] share price is $21.41. The Score for SNDX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.